Viking Therapeutics, Inc. (NASDAQ:VKTX) average daily volatility for this week is 3.84% which is less than the 5.53% recorded over the past month. Its shares dropped by -67.08% or -$16.1 from its last recorded high of $24 which it attained on September 18 to close at $7.9 per share. Over the past 52 weeks, the shares of Viking Therapeutics, Inc. has been trading as low as $3.69 before witnessing a massive surge by 114.09% or $4.21. This price movement has led to the VKTX stock receiving more attention and has become one to watch out for. It dipped by -1.62% on Thursday and this got the market worried. The stock’s beta now stands at 2.93 and when compared to its 200-day moving average and its 50-day moving average, VKTX price stands -23.47% below and -10.18% below respectively.
Viking Therapeutics, Inc. (VKTX) sank -3.19% this week, a trend that has led to both investors and traders taking note of the stock. Over the past one year, the equity price has embarked on a rally that has seen it rise 32.33% and is now up by 3.27% since start of this year. A look at its monthly performance shows that the stock has recorded a -7.28% fall over the past 30 days. Its equity price dipped by -43.93% over the past three months which led to its overall six-month decrease to stand at -25.26%.
Experts from research firms are bullish about the near-term performance of Viking Therapeutics, Inc. with most of them predicting a $29.79 price target on a short-term (12 months) basis. The average price target by the analysts will see a 277.09% rise in the stock and would lead to VKTX’s market cap to surge to $2.18B. The stock has been rated an average 1.8, which roughly stands towards the bullish end of the spectrum. Reuters looked into the 8 analysts that track Viking Therapeutics, Inc. (NASDAQ:VKTX) and find out that 0 of them rated it as a Hold. 8 of the 8 analysts rated it as a Buy or a Strong Buy while 0 advised investors to desist from buying the stock or sell it if they already possess it.
A look at VKTX technical analysis shows that its 14-day Relative Strength Index (RSI) is in a neutral zone after reaching 42.84 point. Its trading volume has lost -1273797 shares compared to readings over the past three months as it recently exchanged 1786203 shares. This means there is reduced activity from short-term traders as per session, its average trading volume is 3060000 shares, and this is 0.58 times the normal volume.
Analysts have predicted a price target for Tilray, Inc. (TLRY) for 1 year and it stands at an average $131.25/share. This means that it would likely increase by 64.08% from its current position. The current price of the stock has been moving between $76.51 and $80.73. Some brokerage firms have a lower target for the stock than the average, with one of them setting a price target as low as $85. On the other hand, one analyst is super bullish about the price, setting a target as high as $200.
The TLRY stock Stochastic Oscillator (%D) is at 57.82%, which means that it is currently neutral. The shares P/S ratio stands at 223.7 which compares to the 7.71 recorded by the industry or the 10.06 by the wider sector. The stock currently has an estimated price-earnings (P/E) multiple of 0, which is lower than the 0 multiple of 12-month price-earnings (P/E). The company’s earnings have gone down, with a quarterly decrease rate of 0% over the past five years.
Analysts view Tilray, Inc. (NASDAQ:TLRY) as a Hold, with 2.5 consensus rating. Reuters surveyed 6 analysts that follow TLRY and found that 3 of those analysts rated the stock as a Hold. The remaining 3 were divided, with 3 analyst rating it as a Buy or a Strong Buy while 0 analysts advised investors to desist from buying Tilray, Inc. (TLRY) shares or sell it if they already own it.